News

Relevant Health Holds Demo Day for Its Inaugural Cohort of Health Tech Startups

Relevant

At its first Demo Day on March 23, Relevant Health, a health technology startup accelerator in the Washington, DC metro area, hosted a group of more than 150 investors, industry leaders and top technology company representatives to experience first-hand the progress of the accelerator’s seven health tech startups. Coming from Bethesda, Rockville, Washington, DC, Baltimore, […]

Comments Off on Relevant Health Holds Demo Day for Its Inaugural Cohort of Health Tech Startups Continue Reading →

Vtesse, Inc. Announces Phase 1/2 Clinical Data

Vtesse, Inc. logo (PRNewsFoto/Vtesse, Inc.)

Vtesse, Inc. announced in early March data from a Phase 1/2 clinical trial demonstrating a reduction in the rate of Niemann-Pick Type C1 (NPC1) Disease progression from Vtesse’s lead drug candidate VTS-270. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Center for Advancing Translational Sciences, two components […]

Congratulations to WellDoc on Recent Collaboration and Financing

WellDoc

In early March, WellDoc announced a strategic collaboration with LifeScan and that it had received investment from Johnson & Johnson Innovation, bringing its total Series B raise to $29.5 million. Under the collaboration, WellDoc’s BlueStar® product, the first FDA-cleared digital therapeutic for adults who live with Type 2 diabetes, will be integrated with LifeScan’s OneTouchVerio […]

Comments Off on Congratulations to WellDoc on Recent Collaboration and Financing Continue Reading →

$GLYC CFO Provides Testimony Before House Capital Markets Subcommittee

logo-glyco

Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony today on behalf of the Biotechnology Industry Organization (BIO) before the House Subcommittee on Capital Markets and Government Sponsored Enterprises. Hahn serves as the Co-Chair of BIO’s Finance & Tax Committee. Hahn testified in support of the Fostering Innovation Act, which would extend the JOBS […]

Comments Off on $GLYC CFO Provides Testimony Before House Capital Markets Subcommittee Continue Reading →

Facilitating IMET REEF Weekend on Strategic Comms & Messaging for 2nd Year in a Row

IMET

On November 7, PressComm PR Principal & Founder Jamie Lacey-Moreira joined Institute for Marine & Environmental Technology (IMET) Assistant Director Nick Hammond to facilitate a workshop focused on strategic communications and messaging for the second year in a row. Four graduate students/entrepreneurs attended as part of a program called REEF. IMET is a joint University […]

Comments Off on Facilitating IMET REEF Weekend on Strategic Comms & Messaging for 2nd Year in a Row Continue Reading →

Relevant Health Unveils Roster of Startups for Its Inaugural Program

Relevant

Relevant Health, a health technology startup accelerator in the Washington, DC metro area, welcomes its inaugural class. The selected startups come to Relevant Health from its backyard of Bethesda and Rockville, as well as Washington, DC, Baltimore, New York City, and Latvia. This week, the cohort of startups embarks on a five-month program that involves […]

Comments Off on Relevant Health Unveils Roster of Startups for Its Inaugural Program Continue Reading →

Congratulations to UMB Entrepreneur of the Year Chris Meenan

CM

Enthusiastic, animated, and innovative, Christopher Meenan left no doubt why he was among UMB’s 2015 Founders Week award winners with an insightful and entertaining Entrepreneur of the Year presentation “Health Informatics: A New Frontier for Innovation in Medicine” on Oct. 21. Meenan, a faculty research associate in the School of Medicine’s Department of Diagnostic Radiology […]

Comments Off on Congratulations to UMB Entrepreneur of the Year Chris Meenan Continue Reading →

PressComm PR’s Interview with Eddy C. Agbo of Fyodor Biotechnologies for UM BioPark

agbo

This fall we had the chance to catch up with Dr. Eddy C. Agbo, who is the Chairman and CEO of Fyodor Biotechnologies. We asked him about his company; see his answers below. Tell us about your company: Fyodor is a socially responsible biotechnology company that addresses urgent global healthcare needs in emerging economies. Fyodor […]

Comments Off on PressComm PR’s Interview with Eddy C. Agbo of Fyodor Biotechnologies for UM BioPark Continue Reading →